Effects of spatially limited external magnetic fields on short sample tests of large-scale superconductors

For short sample tests of large-scale superconductor coil conductors, it is difficult to get sufficient spatial uniformity using external magnetic fields because of the size limitations of test facilities. The effects of spatially limited external magnetic fields on short sample tests are discussed by comparing the test results for narrow and broad external magnetic fields. The authors tested short samples of pool-cooled 10 kA class superconductors using two kinds of split coils which are different in bore size. The measured recovery currents for the narrow external field are more than twice those for the broad field. It shows that the insufficient spatial distribution of the external field biases the stability measurements of superconductor

Superconductivity in correlated disordered two-dimensional electron gas

We calculate the dynamic effective electron-electron interaction potential for a low density disordered two-dimensional electron gas. The disordered response function is used to calculate the effective potential where the scattering rate is taken from typical mobilities from recent experiments. We investigate the development of an effective attractive pair potential for both disordered and disorder free systems with correlations determined from existing numerical simulation data. The effect of disorder and correlations on the superconducting critical temperature Tc is discussed.Comment: 4 pages, RevTeX + epsf, 4 figure

Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

We examined estrogen receptor (ER) mRNA expression and molecular subtypes in stage I-III breast cancers that are progesterone receptor (PR) positive but ER and HER2 negative by immunohistochemistry (IHC) or fluorescent in situ hybridization. The ER, PR, and HER2 status was determined by IHC as part of routine clinical assessment (N = 501). Gene expression profiling was done with the Affymetrix U133A gene chip. We compared expressions of ESR1 and MKI67 mRNA, distribution of molecular subtypes by the PAM50 classifier, the sensitivity to endocrine therapy index, and the DLDA30 chemotherapy response predictor signature among ER/PR-positive (n = 223), ER-positive/PR-negative (n = 73), ER-negative/PR-positive (n = 20), and triple-negative (n = 185) cancers. All patients received neoadjuvant chemotherapy with an anthracycline and taxane and had adjuvant endocrine therapy only if ER or PR > 10 % positive. ESR1 expression was high in 25 % of ER-negative/PR-positive, in 79 % of ER-positive/PR-negative, in 96 % of ER/PR-positive, and in 12 % of triple-negative cancers by IHC. The average MKI67 expression was significantly higher in the ER-negative/PR-positive and triple-negative cohorts. Among the ER-negative/PR-positive patients, 15 % were luminal A, 5 % were Luminal B, and 65 % were basal like. The relapse-free survival rate of ER-negative/PR-positive patients was equivalent to ER-positive cancers and better than the triple-negative cohort. Only 20-25 % of the ER-negative/PR-positive tumors show molecular features of ER-positive cancers. In this rare subset of patients (i) a second RNA-based assessment may help identifying the minority of ESR1 mRNA-positive, luminal-type cancers and (ii) the safest clinical approach may be to consider both adjuvant endocrine and chemotherapy

Neoadjuvant Chemotherapy with or without Concurrent Hormone Therapy in Estrogen Receptor-Positive Breast Cancer:NACED-Randomized Multicenter Phase II Trial

Although in the neoadjuvant setting for estrogen receptor (ER)-positive breast cancers, chemotherapy or hormone therapy alone does not result in satisfactory tumor response, it is unknown whether concurrent chemo-endocrine therapy is superior to chemotherapy alone in clinical outcomes. We conducted a randomized phase II trial to test the responses of ER-positive patients to concurrent administration of chemo-endocrine therapy in the neoadjuvant setting. Women with stage II-III, ER-positive, invasive breast cancer (n=28) received paclitaxel followed by fluorouracil, epirubicin, cyclophosphamide (T-FEC) and were randomized to receive concurrent chemo-endocrine therapy consisting of goserelin administered subcutaneously for premenopausal women or an aromatase inhibitor for postmenopausal women. The primary endpoint was the pathological complete response (pCR) rate after neoadjuvant therapy. Twenty-eight patients were randomized. There were no significant differences in pCR rate between the concurrent group (12.5%;2/16) and the chemotherapy alone group (8.3%;1/12). Tumor size after therapy was significantly reduced in the concurrent therapy group (p=0.035), but not in the chemotherapy-alone group (p=0.622). Neoadjuvant chemotherapy with concurrent hormone therapy provided no significant improvement in pCR rate in ER-positive breast cancers. These preliminary results should be followed up by further studies

The C-Terminal Fragment of Prostate-Specific Antigen, a 2331 Da Peptide, as a New Urinary Pathognomonic Biomarker Candidate for Diagnosing Prostate Cancer

Background and Objectives: Prostate cancer (PCa) is one of the most common cancers and leading cause of cancer-related deaths in men. Mass screening has been carried out since the 1990s using prostate-specific antigen (PSA) levels in the serum as a PCa biomarker. However, although PSA is an excellent organ-specific marker, it is not a cancer-specific marker. Therefore, the aim of this study was to discover new biomarkers for the diagnosis of PCa. Materials and Methods: We focused on urine samples voided following prostate massage (digital rectal examination [DRE]) and conducted a peptidomic analysis of these samples using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS_n). Urinary biomaterials were concentrated and desalted using CM-Sepharose prior to the following analyses being performed by MALDI-TOF/MS_n: 1) differential analyses of mass spectra; 2) determination of amino acid sequences; and 3) quantitative analyses using a stable isotope-labeled internal standard. Results: Multivariate analysis of the MALDI-TOF/MS mass spectra of urinary extracts revealed a 2331 Da peptide in urine samples following DRE. This peptide was identified as a C-terminal PSA fragment composed of 19 amino acid residues. Moreover, quantitative analysis of the relationship between isotope-labeled synthetic and intact peptides using MALDI-TOF/MS revealed that this peptide may be a new pathognomonic biomarker candidate that can differentiate PCa patients from non-cancer subjects. Conclusion: The results of the present study indicate that the 2331 Da peptide fragment of PSA may become a new pathognomonic biomarker for the diagnosis of PCa. A further large-scale investigation is currently underway to assess the possibility of using this peptide in the early detection of PCa

Neutrino Opacities in Neutron Stars with Kaon Condensates

The neutrino mean free paths in hot neutron-star matter are obtained in the presence of kaon condensates. The kaon-induced neutrino absorption process, which is allowed only in the presence of kaon condensates, is considered for both nondegenerate and degenerate neutrinos. The neutrino mean free path due to this process is compared with that for the neutrino-nucleon scattering. While the mean free path for the kaon-induced neutrino absorption process is shown to be shorter than the ordinary two-nucleon absorption process by several orders of magnitude when temperature is not very high, the neutrino-nucleon scattering process has still a dominant contribution to the neutrino opacity. Thus, the kaon-induced neutrino absorption process has a minor effect on the thermal and dynamical evolution of protoneutron stars.Comment: 35 pages, 4 figure

Nonequilibrium Weak Processes in Kaon Condensation II - Kinetics of condensation ---

The kinetics of negatively charged kaon condensation in the early stages of a newly born neutron star is considered. The thermal kaon process, in which kaons are thermally produced by nucleon-nucleon collisions, is found to be dominant throughout the equilibration process. Temporal changes of the order parameter of the condensate and the number densities of the chemical species are obtained from the rate equations, which include the thermal kaon reactions as well as the kaon-induced Urca and the modified Urca reactions. It is shown that the dynamical evolution of the condensate is characterized by three stages: the first, prior to establishment of a condensate, the second, during the growth and subsequent saturation of the condensate, and the third, near chemical equilibrium. The connection between the existence of a soft kaon mode and the instability of the noncondensed state is discussed. Implications of the nonequilibrium process on the possible delayed collapse of a protoneutron star are also mentioned.Comment: 27 pages, incl. 8 eps figures, RevTe

Optical conductivity from local anharmonic phonons

Recently there has been paid much attention to phenomena caused by local anharmonic vibrations of the guest ions encapsulated in polyhedral cages of materials such as pyrochlore oxides, filled skutterdites and clathrates. We theoretically investigate the optical conductivity solely due to these so-called rattling phonons in a one-dimensional anharmonic potential model. The dipole interaction of the guest ions with electric fields induces excitations expressed as transitions among vibrational states with non-equally spaced energies, resulting in a natural line broadening and a shift of the peak frequency as anharmonic effects. In the case of a single well potential, a softening of the peak frequency and an asymmetric narrowing of the line width with decreasing temperature are understood as a shift of the spectral weight to lower level transitions. On the other hand, the case of a double minima potential leads to a multi-splitting of a spectral peak in the conductivity spectrum with decreasing temperature.Comment: 8 pages, 11 figures, accepted for publication in Phys. Rev.